Nifedipine Induces Peroxisome Proliferator-Activated Receptor-γ Activation in Macrophages and Suppresses the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice | Zendy

Norio Ishii | Zendy; Takeshi Matsumura | Zendy; Hiroyuki Kinoshita | Zendy; Kazuki Fukuda | Zendy; Hiroyuki Motoshima | Zendy; Takafumi Senokuchi | Zendy; Saya Nakao | Zendy; Atsuyuki Tsutsumi | Zendy; Shokei KimMitsuyama | Zendy; Teruo Kawada | Zendy; Motohiro Takeya | Zendy; Nobuhiro Miyamura | Zendy; Takeshi Nishikawa | Zendy; Eiichi Araki | Zendy

Open Access

Nifedipine Induces Peroxisome Proliferator-Activated Receptor-γ Activation in Macrophages and Suppresses the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice

Author(s) -

Norio Ishii,

Takeshi Matsumura,

Hiroyuki Kinoshita,

Kazuki Fukuda,

Hiroyuki Motoshima,

Takafumi Senokuchi,

Saya Nakao,

Atsuyuki Tsutsumi,

Shokei KimMitsuyama,

Teruo Kawada,

Motohiro Takeya,

Nobuhiro Miyamura,

Takeshi Nishikawa,

Eiichi Araki

Publication year - 2010

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.109.202309

Subject(s) - nifedipine , peroxisome proliferator activated receptor , endocrinology , medicine , phosphorylation , calcium channel , kinase , extracellular , biology , pharmacology , receptor , calcium , microbiology and biotechnology , biochemistry

Nifedipine, an L-type calcium channel blocker, protects against the progression of atherosclerosis. We investigated the molecular basis of the antiatherosclerotic effect of nifedipine in macrophages and apolipoprotein E-deficient mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research